Encompass Health Corporation (EHC) Cash Flow Statement

The consistent ratio above 1.5x suggests depreciation and amortization of around $80 to $95 million per quarter and working capital inflows are doing much of the lifting. Investors should monitor whether this conversion gap narrows, since a persistent divergence between accounting earnings and operating cash may indicate that reported net income understates economic cash generation or that accrual-based revenue recognition, including provisions for doubtful accounts, is masking collection friction.

Quarterly capex has frequently consumed 10 to 15 percent of revenue, which limits FCF margin expansion even as operating cash flow grows. The trajectory points to a business whose free cash generation is real but lumpy, so investors should evaluate FCF on a trailing basis rather than from any single quarter.

Because much of this spending appears growth-oriented rather than purely maintenance, reported FCF understates the cash available if expansion slows. The critical question is the return earned on newly opened facilities, since capital tied up in new builds that take years to mature may pressure near-term free cash flow while the pure-play inpatient model is still being established after the Enhabit separation.

The pattern suggests management is prioritizing hospital construction and debt management over aggressive shareholder returns during periods of heavier capex. Investors should watch whether buybacks resume at a higher run-rate once capex normalizes, as the current allocation appears to favor reinvestment over distribution.